Carson Wealth (CWM LLC)’s Anavex Life Sciences AVXL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32K | Buy |
3,482
+364
| +12% | +$3.35K | ﹤0.01% | 3600 |
|
|
2025
Q1 | $27K | Buy |
3,118
+31
| +1% | +$268 | ﹤0.01% | 3452 |
|
|
2024
Q4 | $33K | Sell |
3,087
-363
| -11% | -$3.88K | ﹤0.01% | 3093 |
|
|
2024
Q3 | $20K | Buy |
3,450
+2,104
| +156% | +$12.2K | ﹤0.01% | 3339 |
|
|
2024
Q2 | $6K | Buy |
1,346
+1,166
| +648% | +$5.2K | ﹤0.01% | 3746 |
|
|
2024
Q1 | $1K | Sell |
180
-65
| -27% | -$361 | ﹤0.01% | 4071 |
|
|
2023
Q4 | $2K | Sell |
245
-413
| -63% | -$3.37K | ﹤0.01% | 3773 |
|
|
2023
Q3 | $4K | Buy |
658
+247
| +60% | +$1.5K | ﹤0.01% | 3527 |
|
|
2023
Q2 | $3K | Sell |
411
-25
| -6% | -$182 | ﹤0.01% | 3594 |
|
|
2023
Q1 | $4K | Buy |
436
+350
| +407% | +$3.21K | ﹤0.01% | 3351 |
|
|
2022
Q4 | $1K | Buy |
+86
| New | +$1K | ﹤0.01% | 3683 |
|
|
2022
Q1 | – | Sell |
-28
| Closed | – | – | 3497 |
|
|
2021
Q4 | $0 | Buy |
+28
| New | – | ﹤0.01% | 3463 |
|
|
2021
Q2 | $5K | Hold |
200
| – | – | ﹤0.01% | 2329 |
|
|
2021
Q1 | $5K | Hold |
200
| – | – | ﹤0.01% | 2329 |
|
|
2020
Q4 | $5K | Hold |
200
| – | – | ﹤0.01% | 2329 |
|
|
2020
Q3 | $5K | Hold |
200
| – | – | ﹤0.01% | 2329 |
|
|
2020
Q2 | $5K | Hold |
200
| – | – | ﹤0.01% | 2329 |
|
|
2020
Q1 | $5K | Hold |
200
| – | – | ﹤0.01% | 2329 |
|
|
2019
Q4 | $5K | Hold |
200
| – | – | ﹤0.01% | 2329 |
|
|
2019
Q3 | $5K | Hold |
200
| – | – | ﹤0.01% | 2329 |
|
|
2019
Q2 | $5K | Hold |
200
| – | – | ﹤0.01% | 2329 |
|
|
2019
Q1 | $5K | Sell |
200
-5,800
| -97% | -$145K | ﹤0.01% | 2329 |
|
|
2018
Q4 | $9K | Buy |
+6,000
| New | +$9K | ﹤0.01% | 1349 |
|